Revance Therapeutics Inc Takeover accepted line
Sell:298.19pBuy:298.19p
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:298.19p
Buy:298.19p
Change:No change
No changePrices delayed by at least 15 minutes
Sell:298.19p
Buy:298.19p
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 6 February 2025 | Mark J FoleyPresident/CEO | Sell Regular sell transaction (market) | 84,686 | $3.65 | $309,103.90 | 0 |
| 6 February 2025 | Angus Charles RussellDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Christian W (Chris) NoletDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Jill BeraudDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Vladimir (Vlad) CoricDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Carey O'Connor KolajaDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Olivia C WareDirector | Sell Regular sell transaction (market) | 15,000 | $3.65 | $54,750.00 | 0 |
| 6 February 2025 | Erica JordanChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 107,942 | $3.65 | $393,988.30 | 0 |
| 6 February 2025 | David HollanderOther Level A | Sell Regular sell transaction (market) | 95,212 | $3.65 | $347,523.80 | 0 |
| 6 February 2025 | Mark J FoleyPresident/CEO | Sell Regular sell transaction (market) | 27,933 | $3.65 | $101,955.45 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 February 2025 | Mark J FoleyPresident/CEO | Sell Regular sell transaction (market) | 996,935 | $3.65 | $3,638,812.75 | 27,933 |
| 4 February 2025 | Mark J FoleyPresident/CEO | Sell Regular sell transaction (market) | 110,913 | $3.65 | $404,832.45 | 0 |
| 6 February 2025 | Erica JordanChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 107,942 | $3.65 | $393,988.30 | 0 |
| 6 February 2025 | Tobin SchilkeCFO | Sell Regular sell transaction (market) | 103,555 | $3.65 | $377,975.75 | 0 |
| 4 February 2025 | Tobin SchilkeCFO | Sell Regular sell transaction (market) | 97,999 | $3.65 | $357,696.35 | 103,555 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.